Skip to main content
SpringerLink
Log in

Selpercatinib beim fortgeschrittenen medullären Schilddrüsenkarzinom

Selpercatinib for the treatment of advanced medullary thyroid cancer

  • Journal Club
  • Published:
Die Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Wirth LJES et al Efficacy of Selpercatinib in RET-altered thyroid cancers. https://doi.org/10.1056/NEJMoa2005651

  2. Haddad RI, Bischoff L et al Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology https://doi.org/10.6004/jnccn.2022.0040

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Allgemein‑, Viszeral- und Tumorchirurgie, Universitätsklinikum Köln (AöR), Kerpener Str. 62, 50937, Köln, Deutschland

    Aylin Pamuk, Costanza Chiapponi, Hakan Alakus & Milan J. M. Hartmann

  2. Zentrale Dienstleistungseinrichtung für Transfusionsmedizin, Universitätsklinikum Köln (AöR), Kerpener Str. 62, 50937, Köln, Deutschland

    Aylin Pamuk

Authors
  1. Aylin Pamuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Costanza Chiapponi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hakan Alakus
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Milan J. M. Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Milan J. M. Hartmann.

Ethics declarations

Interessenkonflikt

A. Pamuk, C. Chiapponi, H. Alakus und M.J. Hartmann geben an, dass kein Interessenkonflikt besteht.

Additional information

Hinweis des Verlags

Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pamuk, A., Chiapponi, C., Alakus, H. et al. Selpercatinib beim fortgeschrittenen medullären Schilddrüsenkarzinom. Onkologie 30, 421–422 (2024). https://doi.org/10.1007/s00761-024-01518-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-024-01518-x

Search

Navigation